The DOI matches its Crossref record; 190 of the 190 references it cites were found in a registry or an index.
Clinical implications of intratumor heterogeneity: challenges and opportunities
Open accessAbstract
In this review, we highlight the role of intratumoral heterogeneity, focusing on the clinical and biological ramifications this phenomenon poses. Intratumoral heterogeneity arises through complex genetic, epigenetic, and protein modifications that drive phenotypic selection in response to environmental pressures. Functionally, heterogeneity provides tumors with significant adaptability. This ranges from mutual beneficial cooperation between cells, which nurture features such as growth and metastasis, to the narrow escape and survival of clonal cell populations that have adapted to thrive under specific conditions such as hypoxia or chemotherapy. These dynamic intercellular interplays are guided by a Darwinian selection landscape between clonal tumor cell populations and the tumor microenvironment. Understanding the involved drivers and functional consequences of such tumor heterogeneity is challenging but also promises to provide novel insight needed to confront the problem of therapeutic resistance in tumors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
The cancer genome atlas pan-cancer analysis project
The Cancer Genome Atlas Research Network, Weinstein, J. N., Collisson, E. A., Mills, G. B., Shaw, K. R. M., Ozenberger, B. A., Ellrott, K., Shmulevich, I., Sander, C., & Stuart, J. M. (2013) · Nature Genetics · doi:10.1038/ng.2764 · Cited by 9,092
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
Bettegowda, C., Sausen, M., Leary, R. J., Kinde, I., Wang, Y., Agrawal, N., Bartlett, B. R., Wang, H., Luber, B., Alani, R. M., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007094 · Cited by 5,067
Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma
Patel, A. P., Tirosh, I., Trombetta, J. J., Shalek, A. K., Gillespie, S. M., Wakimoto, H., Cahill, D. P., Nahed, B. V., Curry, W. T., Martuza, R. L., et al. (2014) · Science · doi:10.1126/science.1254257 · Cited by 5,063
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli, F., Fishbane, S., Block, G. A., & Macdougall, I. C. (2017) · American Journal of Nephrology · doi:10.1159/000455166 · Cited by 4,813
Hammond, M. E. H., Hayes, D. F., Dowsett, M., Allred, D. C., Hagerty, K. L., Badve, S., Fitzgibbons, P. L., Francis, G., Goldstein, N. S., Hayes, M., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.6529 · Cited by 4,213
Tumour heterogeneity and resistance to cancer therapies
Dagogo-Jack, I., & Shaw, A. T. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.166 · Cited by 3,846
Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors
Sequist, L. V., Waltman, B. A., Dias-Santagata, D., Digumarthy, S., Turke, A. B., Fidias, P., Bergethon, K., Shaw, A. T., Gettinger, S., Cosper, A. K., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002003 · Cited by 3,499
Clonal heterogeneity and tumor evolution: past, present, and the future
McGranahan, N., & Swanton, C. (2017) · Cell · doi:10.1016/j.cell.2017.01.018 · Cited by 2,840
The landscape of long noncoding RNAs in the human transcriptome
Iyer, M. K., Niknafs, Y. S., Malik, R., Singhal, U., Sahu, A., Hosono, Y., Barrette, T. R., Prensner, J. R., Evans, J. R., Zhao, S., et al. (2015) · Nature Genetics · doi:10.1038/ng.3192 · Cited by 2,738
Tumour heterogeneity and cancer cell plasticity
Meacham, C. E., & Morrison, S. J. (2013) · Nature · doi:10.1038/nature12624 · Cited by 2,446
Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis
Aceto, N., Bardia, A., Miyamoto, D. T., Donaldson, M. C., Wittner, B. S., Spencer, J. A., Yu, M., Pely, A., Engstrom, A., Zhu, H., et al. (2014) · Cell · doi:10.1016/j.cell.2014.07.013 · Cited by 2,441
Tracking the Evolution of Non–Small-Cell Lung Cancer
Jamal-Hanjani, M., Wilson, G. A., McGranahan, N., Birkbak, N. J., Watkins, T. B. K., Veeriah, S., Shafi, S., Johnson, D. H., Mitter, R., Rosenthal, R., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1616288 · Cited by 2,349
An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
Newman, A. M., Bratman, S. V., To, J., Wynne, J. F., Eclov, N. C. W., Modlin, L. A., Liu, C. L., Neal, J. W., Wakelee, H. A., Merritt, R. E., et al. (2014) · Nature Medicine · doi:10.1038/nm.3519 · Cited by 2,220
Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
Dawson, S.-J., Tsui, D. W. Y., Murtaza, M., Biggs, H., Rueda, O. M., Chin, S.-F., Dunning, M. J., Gale, D., Forshew, T., Mahler-Araujo, B., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1213261 · Cited by 2,207
MicroRNA biogenesis pathways in cancer
Lin, S., & Gregory, R. I. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3932 · Cited by 2,112
Intra-tumour heterogeneity: a looking glass for cancer?
Marusyk, A., Almendro, V., & Polyak, K. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3261 · Cited by 2,000
Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing
Ding, L., Ley, T. J., Larson, D. E., Miller, C. A., Koboldt, D. C., Welch, J. S., Ritchey, J. K., Young, M. A., Lamprecht, T., McLellan, M. D., et al. (2012) · Nature · doi:10.1038/nature10738 · Cited by 1,993
Glioma Groups Based on 1p/19q,IDH, and TERT Promoter Mutations in Tumors
Eckel-Passow, J. E., Lachance, D. H., Molinaro, A. M., Walsh, K. M., Decker, P. A., Sicotte, H., Pekmezci, M., Rice, T., Kosel, M. L., Smirnov, I. V., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1407279 · Cited by 1,982
Integrating liquid biopsies into the management of cancer
Siravegna, G., Marsoni, S., Siena, S., & Bardelli, A. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.14 · Cited by 1,908
Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution
The TRACERx consortium, Abbosh, C., The PEACE consortium, Birkbak, N. J., Wilson, G. A., Jamal-Hanjani, M., Constantin, T., Salari, R., Le Quesne, J., Moore, D. A., et al. (2017) · Nature · doi:10.1038/nature22364 · Cited by 1,874
Pan-cancer patterns of somatic copy number alteration
Zack, T. I., Schumacher, S. E., Carter, S. L., Cherniack, A. D., Saksena, G., Tabak, B., Lawrence, M. S., Zhang, C.-Z., Wala, J., Mermel, C. H., et al. (2013) · Nature Genetics · doi:10.1038/ng.2760 · Cited by 1,870
Principles of cancer therapy: oncogene and non-oncogene addiction
Luo, J., Solimini, N. L., & Elledge, S. J. (2009) · Cell · doi:10.1016/j.cell.2009.02.024 · Cited by 1,765
The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers
Diaz Jr, L. A., Williams, R. T., Wu, J., Kinde, I., Hecht, J. R., Berlin, J., Allen, B., Bozic, I., Reiter, J. G., Nowak, M. A., et al. (2012) · Nature · doi:10.1038/nature11219 · Cited by 1,713
HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression
Keith, B., Johnson, R. S., & Simon, M. C. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3183 · Cited by 1,693
Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA
Murtaza, M., Dawson, S.-J., Tsui, D. W. Y., Gale, D., Forshew, T., Piskorz, A. M., Parkinson, C., Chin, S.-F., Kingsbury, Z., Wong, A. S. C., et al. (2013) · Nature · doi:10.1038/nature12065 · Cited by 1,624
Cao, J., Packer, J. S., Ramani, V., Cusanovich, D. A., Huynh, C., Daza, R., Qiu, X., Lee, C., Furlan, S. N., Steemers, F. J., et al. (2017) · doi:10.1101/104844 · Cited by 1,402
Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy
Alix-Panabières, C., & Pantel, K. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-1483 · Cited by 1,394
Evolution and impact of subclonal mutations in chronic lymphocytic leukemia
Landau, D. A., Carter, S. L., Stojanov, P., McKenna, A., Stevenson, K., Lawrence, M. S., Sougnez, C., Stewart, C., Sivachenko, A., Wang, L., et al. (2013) · Cell · doi:10.1016/j.cell.2013.01.019 · Cited by 1,379
Forshew, T., Murtaza, M., Parkinson, C., Gale, D., Tsui, D. W. Y., Kaper, F., Dawson, S.-J., Piskorz, A. M., Jimenez-Linan, M., Bentley, D., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003726 · Cited by 1,297
Tumour heterogeneity in the clinic
Bedard, P. L., Hansen, A. R., Ratain, M. J., & Siu, L. L. (2013) · Nature · doi:10.1038/nature12627 · Cited by 1,211
Non-Invasive Analysis of Acquired Resistance to Cancer Therapy By Sequencing of Plasma Dna
(2014) · Annals of Oncology · doi:10.1093/annonc/mdu312.5 · Cited by 1,169
Integrated digital error suppression for improved detection of circulating tumor DNA
Newman, A. M., Lovejoy, A. F., Klass, D. M., Kurtz, D. M., Chabon, J. J., Scherer, F., Stehr, H., Liu, C. L., Bratman, S. V., Say, C., et al. (2016) · Nature Biotechnology · doi:10.1038/nbt.3520 · Cited by 1,099
Predicting cancer outcomes from histology and genomics using convolutional networks
Mobadersany, P., Yousefi, S., Amgad, M., Gutman, D. A., Barnholtz-Sloan, J. S., Velázquez Vega, J. E., Brat, D. J., & Cooper, L. A. D. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1717139115 · Cited by 1,084
Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients
Siravegna, G., Mussolin, B., Buscarino, M., Corti, G., Cassingena, A., Crisafulli, G., Ponzetti, A., Cremolini, C., Amatu, A., Lauricella, C., et al. (2015) · Nature Medicine · doi:10.1038/nm.3870 · Cited by 1,082
Biological and therapeutic impact of intratumor heterogeneity in cancer evolution
McGranahan, N., & Swanton, C. (2015) · Cancer Cell · doi:10.1016/j.ccell.2014.12.001 · Cited by 1,077
Stromal gene expression defines poor-prognosis subtypes in colorectal cancer
Calon, A., Lonardo, E., Berenguer-Llergo, A., Espinet, E., Hernando-Momblona, X., Iglesias, M., Sevillano, M., Palomo-Ponce, S., Tauriello, D. V. F., Byrom, D., et al. (2015) · Nature Genetics · doi:10.1038/ng.3225 · Cited by 1,070
Deep learning as a tool for increased accuracy and efficiency of histopathological diagnosis
Litjens, G., Sánchez, C. I., Timofeeva, N., Hermsen, M., Nagtegaal, I., Kovacs, I., Hulsbergen - van de Kaa, C., Bult, P., van Ginneken, B., & van der Laak, J. (2016) · Scientific Reports · doi:10.1038/srep26286 · Cited by 1,069
Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy
Skoulidis, F., & Heymach, J. V. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0179-8 · Cited by 1,019
Heterogeneity in breast cancer
Polyak, K. (2011) · Journal of Clinical Investigation · doi:10.1172/jci60534 · Cited by 1,006
Yu, K.-H., Zhang, C., Berry, G. J., Altman, R. B., Ré, C., Rubin, D. L., & Snyder, M. (2016) · Nature Communications · doi:10.1038/ncomms12474 · Cited by 972
Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing
Zhang, J., Fujimoto, J., Zhang, J., Wedge, D. C., Song, X., Zhang, J., Seth, S., Chow, C.-W., Cao, Y., Gumbs, C., et al. (2014) · Science · doi:10.1126/science.1256930 · Cited by 965
Best, M. G., Sol, N., Kooi, I., Tannous, J., Westerman, B. A., Rustenburg, F., Schellen, P., Verschueren, H., Post, E., Koster, J., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.09.018 · Cited by 916
Interplay between the Cancer Genome and Epigenome
Shen, H., & Laird, P. W. (2013) · Cell · doi:10.1016/j.cell.2013.03.008 · Cited by 910
De Mattos-Arruda, L., Mayor, R., Ng, C. K. Y., Weigelt, B., Martínez-Ricarte, F., Torrejon, D., Oliveira, M., Arias, A., Raventos, C., Tang, J., et al. (2015) · Nature Communications · doi:10.1038/ncomms9839 · Cited by 865
Self-citationCollective Invasion in Breast Cancer Requires a Conserved Basal Epithelial Program
Cheung, K. J., Gabrielson, E., Werb, Z., & Ewald, A. J. (2013) · Cell · doi:10.1016/j.cell.2013.11.029 · Cited by 833
Translational control in cancer
Silvera, D., Formenti, S. C., & Schneider, R. J. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2824 · Cited by 821
Metastatic Latency and Immune Evasion through Autocrine Inhibition of WNT
Malladi, S., Macalinao, D. G., Jin, X., He, L., Basnet, H., Zou, Y., de Stanchina, E., & Massagué, J. (2016) · Cell · doi:10.1016/j.cell.2016.02.025 · Cited by 791
Pan-cancer analysis of the extent and consequences of intratumor heterogeneity
Andor, N., Graham, T. A., Jansen, M., Xia, L. C., Aktipis, C. A., Petritsch, C., Ji, H. P., & Maley, C. C. (2016) · Nature Medicine · doi:10.1038/nm.3984 · Cited by 768
Protein typing of circulating microvesicles allows real-time monitoring of glioblastoma therapy
Shao, H., Chung, J., Balaj, L., Charest, A., Bigner, D. D., Carter, B. S., Hochberg, F. H., Breakefield, X. O., Weissleder, R., & Lee, H. (2012) · Nature Medicine · doi:10.1038/nm.2994 · Cited by 759
Cheung, K. J., Padmanaban, V., Silvestri, V., Schipper, K., Cohen, J. D., Fairchild, A. N., Gorin, M. A., Verdone, J. E., Pienta, K. J., Bader, J. S., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1508541113 · Cited by 735
Clonal status of actionable driver events and the timing of mutational processes in cancer evolution
McGranahan, N., Favero, F., de Bruin, E. C., Birkbak, N. J., Szallasi, Z., & Swanton, C. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa1408 · Cited by 685
Imaging Intratumor Heterogeneity: Role in Therapy Response, Resistance, and Clinical Outcome
O'Connor, J. P. B., Rose, C. J., Waterton, J. C., Carano, R. A. D., Parker, G. J. M., & Jackson, A. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0990 · Cited by 677
Metastasis as an evolutionary process
Turajlic, S., & Swanton, C. (2016) · Science · doi:10.1126/science.aaf2784 · Cited by 661
Deep learning based tissue analysis predicts outcome in colorectal cancer
Bychkov, D., Linder, N., Turkki, R., Nordling, S., Kovanen, P. E., Verrill, C., Walliander, M., Lundin, M., Haglund, C., & Lundin, J. (2018) · Scientific Reports · doi:10.1038/s41598-018-21758-3 · Cited by 644
Leary, R. J., Sausen, M., Kinde, I., Papadopoulos, N., Carpten, J. D., Craig, D., O’Shaughnessy, J., Kinzler, K. W., Parmigiani, G., Vogelstein, B., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004742 · Cited by 635
Co-evolution of tumor cells and their microenvironment
Polyak, K., Haviv, I., & Campbell, I. G. (2009) · Trends in Genetics · doi:10.1016/j.tig.2008.10.012 · Cited by 628
Genome-scale analysis of aberrant DNA methylation in colorectal cancer
Hinoue, T., Weisenberger, D. J., Lange, C. P. E., Shen, H., Byun, H.-M., Van Den Berg, D., Malik, S., Pan, F., Noushmehr, H., van Dijk, C. M., et al. (2012) · Genome Research · doi:10.1101/gr.117523.110 · Cited by 601
Non-cell-autonomous driving of tumour growth supports sub-clonal heterogeneity
Marusyk, A., Tabassum, D. P., Altrock, P. M., Almendro, V., Michor, F., & Polyak, K. (2014) · Nature · doi:10.1038/nature13556 · Cited by 597
Louis, D. N., Perry, A., Burger, P., Ellison, D. W., Reifenberger, G., von Deimling, A., Aldape, K., Brat, D., Collins, V. P., Eberhart, C., et al. (2014) · Brain Pathology · doi:10.1111/bpa.12171 · Cited by 580
Tumorigenesis: it takes a village
Tabassum, D. P., & Polyak, K. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3971 · Cited by 564
Translational Implications of Tumor Heterogeneity
Jamal-Hanjani, M., Quezada, S. A., Larkin, J., & Swanton, C. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1429 · Cited by 549
Whole-exome sequencing of circulating tumor cells provides a window into metastatic prostate cancer
Lohr, J. G., Adalsteinsson, V. A., Cibulskis, K., Choudhury, A. D., Rosenberg, M., Cruz-Gordillo, P., Francis, J. M., Zhang, C.-Z., Shalek, A. K., Satija, R., et al. (2014) · Nature Biotechnology · doi:10.1038/nbt.2892 · Cited by 535
Development of Personalized Tumor Biomarkers Using Massively Parallel Sequencing
Leary, R. J., Kinde, I., Diehl, F., Schmidt, K., Clouser, C., Duncan, C., Antipova, A., Lee, C., McKernan, K., De La Vega, F. M., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3000702 · Cited by 517
Murtaza, M., Dawson, S.-J., Pogrebniak, K., Rueda, O. M., Provenzano, E., Grant, J., Chin, S.-F., Tsui, D. W. Y., Marass, F., Gale, D., et al. (2015) · Nature Communications · doi:10.1038/ncomms9760 · Cited by 483
Liquid Biopsies, What We Do Not Know (Yet)
Bardelli, A., & Pantel, K. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.01.002 · Cited by 482
Evolution of human BCR–ABL1 lymphoblastic leukaemia-initiating cells
Notta, F., Mullighan, C. G., Wang, J. C. Y., Poeppl, A., Doulatov, S., Phillips, L. A., Ma, J., Minden, M. D., Downing, J. R., & Dick, J. E. (2011) · Nature · doi:10.1038/nature09733 · Cited by 463
Jiménez-Sánchez, A., Memon, D., Pourpe, S., Veeraraghavan, H., Li, Y., Vargas, H. A., Gill, M. B., Park, K. J., Zivanovic, O., Konner, J., et al. (2017) · Cell · doi:10.1016/j.cell.2017.07.025 · Cited by 458
Wang, Y., Springer, S., Zhang, M., McMahon, K. W., Kinde, I., Dobbyn, L., Ptak, J., Brem, H., Chaichana, K., Gallia, G. L., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1511694112 · Cited by 454
Olsson, E., Winter, C., George, A., Chen, Y., Howlin, J., Tang, M. E., Dahlgren, M., Schulz, R., Grabau, D., van Westen, D., et al. (2015) · EMBO Molecular Medicine · doi:10.15252/emmm.201404913 · Cited by 453
Advances in sarcoma genomics and new therapeutic targets
Taylor, B. S., Barretina, J., Maki, R. G., Antonescu, C. R., Singer, S., & Ladanyi, M. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3087 · Cited by 427
Mroz, E. A., & Rocco, J. W. (2013) · Oral Oncology · doi:10.1016/j.oraloncology.2012.09.007 · Cited by 417
Travis, W. D., Brambilla, E., Noguchi, M., Nicholson, A. G., Geisinger, K., Yatabe, Y., Ishikawa, Y., Wistuba, I., Flieder, D. B., Franklin, W., et al. (2013) · Archives of Pathology and Laboratory Medicine · doi:10.5858/arpa.2012-0263-ra · Cited by 414
Genomic alterations in lung adenocarcinoma
Devarakonda, S., Morgensztern, D., & Govindan, R. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00077-7 · Cited by 404
Only three driver gene mutations are required for the development of lung and colorectal cancers
Tomasetti, C., Marchionni, L., Nowak, M. A., Parmigiani, G., & Vogelstein, B. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1421839112 · Cited by 395
De Mattos-Arruda, L., Weigelt, B., Cortes, J., Won, H. H., Ng, C. K. Y., Nuciforo, P., Bidard, F.-C., Aura, C., Saura, C., Peg, V., et al. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu239 · Cited by 386
Self-citationTracking the origins and drivers of subclonal metastatic expansion in prostate cancer
Hong, M. K. H., Macintyre, G., Wedge, D. C., Van Loo, P., Patel, K., Lunke, S., Alexandrov, L. B., Sloggett, C., Cmero, M., Marass, F., et al. (2015) · Nature Communications · doi:10.1038/ncomms7605 · Cited by 372
Non-Oncogene Addiction and the Stress Phenotype of Cancer Cells
Solimini, N. L., Luo, J., & Elledge, S. J. (2007) · Cell · doi:10.1016/j.cell.2007.09.007 · Cited by 365
Chen, W. W., Balaj, L., Liau, L. M., Samuels, M. L., Kotsopoulos, S. K., Maguire, C. A., LoGuidice, L., Soto, H., Garrett, M., Zhu, L. D., et al. (2013) · Molecular Therapy - Nucleic Acids · doi:10.1038/mtna.2013.28 · Cited by 343
Targeting the Eukaryotic Translation Initiation Factor 4E for Cancer Therapy
Graff, J. R., Konicek, B. W., Carter, J. H., & Marcusson, E. G. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5635 · Cited by 332
Seol, H., Lee, H. J., Choi, Y., Lee, H. E., Kim, Y. J., Kim, J. H., Kang, E., Kim, S.-W., & Park, S. Y. (2012) · Modern Pathology · doi:10.1038/modpathol.2012.36 · Cited by 330
Tabernero, J., Lenz, H.-J., Siena, S., Sobrero, A., Falcone, A., Ychou, M., Humblet, Y., Bouché, O., Mineur, L., Barone, C., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00138-2 · Cited by 328
Park, S. Y., Gönen, M., Kim, H. J., Michor, F., & Polyak, K. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40724 · Cited by 324
The Path to Cancer — Three Strikes and You're Out
Vogelstein, B., & Kinzler, K. W. (2015) · New England Journal of Medicine · doi:10.1056/nejmp1508811 · Cited by 323
Role of the tumor microenvironment in tumor progression and the clinical applications (Review)
YUAN, Y., JIANG, Y.-C., SUN, C.-K., & CHEN, Q.-M. (2016) · Oncology Reports · doi:10.3892/or.2016.4660 · Cited by 320
The promise of single-cell sequencing
Eberwine, J., Sul, J.-Y., Bartfai, T., & Kim, J. (2014) · Nature Methods · doi:10.1038/nmeth.2769 · Cited by 304
Pancreatic Cancer Metastases Harbor Evidence of Polyclonality
Maddipati, R., & Stanger, B. Z. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0120 · Cited by 298
Brain Tumor Mutations Detected in Cerebral Spinal Fluid
Pan, W., Gu, W., Nagpal, S., Gephart, M. H., & Quake, S. R. (2015) · Clinical Chemistry · doi:10.1373/clinchem.2014.235457 · Cited by 297
DNA Methylation Screening Identifies Driver Epigenetic Events of Cancer Cell Survival
De Carvalho, D. D., Sharma, S., You, J. S., Su, S.-F., Taberlay, P. C., Kelly, T. K., Yang, X., Liang, G., & Jones, P. A. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.03.045 · Cited by 285
Shi, R., Wang, P.-Y., Li, X.-Y., Chen, J.-X., Li, Y., Zhang, X.-Z., Zhang, C.-G., Jiang, T., Li, W.-B., Ding, W., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4699 · Cited by 285
4E-Binding Protein 1: A Key Molecular “Funnel Factor” in Human Cancer with Clinical Implications
Armengol, G., Rojo, F., Castellví, J., Iglesias, C., Cuatrecasas, M., Pons, B., Baselga, J., & Ramón y Cajal, S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0881 · Cited by 270
Intratumor DNA Methylation Heterogeneity Reflects Clonal Evolution in Aggressive Prostate Cancer
Brocks, D., Assenov, Y., Minner, S., Bogatyrova, O., Simon, R., Koop, C., Oakes, C., Zucknick, M., Lipka, D. B., Weischenfeldt, J., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.06.053 · Cited by 260
Context, tissue plasticity, and cancerAre tumor stem cells also regulated by the microenvironment?
BISSELL, M., & LABARGE, M. (2005) · Cancer Cell · doi:10.1016/s1535-6108(04)00375-7 · Cited by 255
Erratum: Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients
Siravegna, G., Mussolin, B., Buscarino, M., Corti, G., Cassingena, A., Crisafulli, G., Ponzetti, A., Cremolini, C., Amatu, A., Lauricella, C., et al. (2015) · Nature Medicine · doi:10.1038/nm0715-827b · Cited by 255
Complexity in the signaling network: insights from the use of targeted inhibitors in cancer therapy
Logue, J. S., & Morrison, D. K. (2012) · Genes & Development · doi:10.1101/gad.186965.112 · Cited by 250
Association of EGFR L858R Mutation in Circulating Free DNA With Survival in the EURTAC Trial
Karachaliou, N., Mayo-de las Casas, C., Queralt, C., de Aguirre, I., Melloni, B., Cardenal, F., Garcia-Gomez, R., Massuti, B., Sánchez, J. M., Porta, R., et al. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2014.257 · Cited by 239
Rothé, F., Laes, J.-F., Lambrechts, D., Smeets, D., Vincent, D., Maetens, M., Fumagalli, D., Michiels, S., Drisis, S., Moerman, C., et al. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu288 · Cited by 233
Girotti, M. R., Gremel, G., Lee, R., Galvani, E., Rothwell, D., Viros, A., Mandal, A. K., Lim, K. H. J., Saturno, G., Furney, S. J., et al. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-1336 · Cited by 231
Siddiqui, N., & Sonenberg, N. (2015) · Biochemical Society Transactions · doi:10.1042/bst20150126 · Cited by 220
Single-Cell (Multi)omics Technologies
Chappell, L., Russell, A. J. C., & Voet, T. (2018) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-091416-035324 · Cited by 209
Rojo, F., Najera, L., Lirola, J., Jiménez, J., Guzmán, M., Sabadell, M. D., Baselga, J., & Cajal, S. R. Y. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1560 · Cited by 205
Heterogeneous Tumor Subpopulations Cooperate to Drive Invasion
Chapman, A., Fernandez del Ama, L., Ferguson, J., Kamarashev, J., Wellbrock, C., & Hurlstone, A. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.06.045 · Cited by 203
Graff, J. R., Konicek, B. W., Lynch, R. L., Dumstorf, C. A., Dowless, M. S., McNulty, A. M., Parsons, S. H., Brail, L. H., Colligan, B. M., Koop, J. W., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3472 · Cited by 202
Metapopulation dynamics and spatial heterogeneity in cancer
González-García, I., Solé, R. V., & Costa, J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202139299 · Cited by 201
Integrated RNA and DNA sequencing reveals early drivers of metastatic breast cancer
Siegel, M. B., He, X., Hoadley, K. A., Hoyle, A., Pearce, J. B., Garrett, A. L., Kumar, S., Moylan, V. J., Brady, C. M., Van Swearingen, A. E. D., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci96153 · Cited by 183
Trinh, A., Trumpi, K., De Sousa E Melo, F., Wang, X., de Jong, J. H., Fessler, E., Kuppen, P. J. K., Reimers, M. S., Swets, M., Koopman, M., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0680 · Cited by 180
Cancer Systems Biology: a peek into the future of patient care?
Werner, H. M. J., Mills, G. B., & Ram, P. T. (2014) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2014.6 · Cited by 178
Castellvi, J., Garcia, A., Rojo, F., Ruiz‐Marcellan, C., Gil, A., Baselga, J., & Ramon y Cajal, S. (2006) · Cancer · doi:10.1002/cncr.22195 · Cited by 177
Multifocal epithelial tumors and field cancerization: stroma as a primary determinant
Dotto, G. P. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72589 · Cited by 175
Circulating tumour cells and cell-free DNA as tools for managing breast cancer
De Mattos-Arruda, L., Cortes, J., Santarpia, L., Vivancos, A., Tabernero, J., Reis-Filho, J. S., & Seoane, J. (2013) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2013.80 · Cited by 174
Self-citationMichaut, M., Chin, S.-F., Majewski, I., Severson, T. M., Bismeijer, T., de Koning, L., Peeters, J. K., Schouten, P. C., Rueda, O. M., Bosma, A. J., et al. (2016) · Scientific Reports · doi:10.1038/srep18517 · Cited by 173
Radiogenomic Analysis of Breast Cancer Using MRI: A Preliminary Study to Define the Landscape
Yamamoto, S., Maki, D. D., Korn, R. L., & Kuo, M. D. (2012) · American Journal of Roentgenology · doi:10.2214/ajr.11.7824 · Cited by 172
Synovial Sarcoma: Recent Discoveries as a Roadmap to New Avenues for Therapy
Nielsen, T. O., Poulin, N. M., & Ladanyi, M. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-1246 · Cited by 172
Djuric, U., Zadeh, G., Aldape, K., & Diamandis, P. (2017) · npj Precision Oncology · doi:10.1038/s41698-017-0022-1 · Cited by 171
Musa, J., Orth, M. F., Dallmayer, M., Baldauf, M., Pardo, C., Rotblat, B., Kirchner, T., Leprivier, G., & Grünewald, T. G. P. (2016) · Oncogene · doi:10.1038/onc.2015.515 · Cited by 170
Translating cancer genomes and transcriptomes for precision oncology
Roychowdhury, S., & Chinnaiyan, A. M. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21329 · Cited by 168
Genomic and immune heterogeneity are associated with differential responses to therapy in melanoma
Reuben, A., Spencer, C. N., Prieto, P. A., Gopalakrishnan, V., Reddy, S. M., Miller, J. P., Mao, X., De Macedo, M. P., Chen, J., Song, X., et al. (2017) · npj Genomic Medicine · doi:10.1038/s41525-017-0013-8 · Cited by 166
Janiszewska, M., Liu, L., Almendro, V., Kuang, Y., Paweletz, C., Sakr, R. A., Weigelt, B., Hanker, A. B., Chandarlapaty, S., King, T. A., et al. (2015) · Nature Genetics · doi:10.1038/ng.3391 · Cited by 163
Moelans, C. B., Verschuur‐Maes, A. H. J., & van Diest, P. J. (2011) · The Journal of Pathology · doi:10.1002/path.2930 · Cited by 158
Molecular Pathways: How Can BRCA-Mutated Tumors Become Resistant to PARP Inhibitors?
Bouwman, P., & Jonkers, J. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0225 · Cited by 158
Lynch Syndrome: An Updated Review
Sehgal, R., Sheahan, K. D., O’Connell, P. R., Hanly, A. M., Martin, S., & Winter, D. C. (2014) · Genes · doi:10.3390/genes5030497 · Cited by 153
Yoshizawa, A., Fukuoka, J., Shimizu, S., Shilo, K., Franks, T. J., Hewitt, S. M., Fujii, T., Cordon‐Cardo, C., Jen, J., & Travis, W. D. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0986 · Cited by 148
Cell‐free circulating tumour DNA as a liquid biopsy in breast cancer
Mattos‐Arruda, L. D., & Caldas, C. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2015.12.001 · Cited by 141
Korshunova, Y. O., Maloney, R. K., Lakey, N. D., Citek, R. W., Bacher, B., Budiman, A., Ordway, J. M., McCombie, W. R., Leon, J., Jeddeloh, J. A., et al. (2007) · Genome Research · doi:10.1101/gr.6883307 · Cited by 138
Dotto, G. P., Weinberg, R. A., & Ariza, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.17.6389 · Cited by 137
Emerging Understanding of Multiscale Tumor Heterogeneity
Gerdes, M. J., Sood, A., Sevinsky, C. J., Pris, A. D., Zavodszky, M. I., & Ginty, F. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00366 · Cited by 131
Epigenetics in ovarian cancer: premise, properties, and perspectives
Yang, Q., Yang, Y., Zhou, N., Tang, K., Lau, W. B., Lau, B., Wang, W., Xu, L., Yang, Z., Huang, S., et al. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0855-4 · Cited by 131
Pérez‐Villamil, B., Romera-López, A., Prieto, S. H., López–Campos, G., Calles, A., Asenjo, J. A. L., Sanz‐Ortega, J., Fernández, C., Sastre, J., Alfonso, R., et al. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-260 · Cited by 126
The molecular basis of breast cancer pathological phenotypes
Heng, Y. J., Lester, S. C., Tse, G. M.-K., Factor, R. E., Allison, K. H., Collins, L. C., Chen, Y., Jensen, K. C., Johnson, N. B., Jeong, J. C., et al. (2016) · The Journal of Pathology · doi:10.1002/path.4847 · Cited by 122
Penman, C. L., Faulkner, C., Lowis, S. P., & Kurian, K. M. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00054 · Cited by 119
Gerlinger, M., Quezada, S. A., Peggs, K. S., Furness, A. J. S., Fisher, R. A., Marafioti, T., Shende, V. H., McGranahan, N., Rowan, A., Hazell, S., et al. (2013) · The Journal of Pathology · doi:10.1002/path.4284 · Cited by 115
Fan, S., Ramalingam, S. S., Kauh, J. S. W., Xu, Z., Khuri, F. R., & Sun, S. (2009) · Cancer Biology & Therapy · doi:10.4161/cbt.8.15.8960 · Cited by 111
Liquid biopsies in patients with diffuse glioma
Best, M. G., Sol, N., Zijl, S., Reijneveld, J. C., Wesseling, P., & Würdinger, T. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1399-y · Cited by 104
How to design a single-cell RNA-sequencing experiment: pitfalls, challenges and perspectives
Molin, A. D., & Camillo, B. D. (2018) · Briefings in Bioinformatics · doi:10.1093/bib/bby007 · Cited by 104
BRAF Mutations: Signaling, Epidemiology, and Clinical Experience in Multiple Malignancies
Hall, R. D., & Kudchadkar, R. R. (2014) · Cancer Control · doi:10.1177/107327481402100307 · Cited by 103
Hoadley, K. A., Siegel, M. B., Kanchi, K., Miller, C. A., Ding, L., Wei, Z., He, X., Parker, J. S., Wendl, M. C., Fulton, R. S., et al. (2016) · PLoS Medicine · doi:10.1371/journal.pmed.1002174 · Cited by 100
The Emerging Role of Epitranscriptomics in Cancer: Focus on Urological Tumors
Lobo, J., Barros‐Silva, D., Henrique, R., & Jerónimo, C. (2018) · Genes · doi:10.3390/genes9110552 · Cited by 91
Wang, W.-Q., Liu, L., Xu, H., Luo, G., Chen, T., Wu, C., Xu, Y.-F., Xu, J., Liu, C., Zhang, B., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071189 · Cited by 88
Aberrant Splicing of Estrogen Receptor, HER2, and CD44 Genes in Breast Cancer
Inoue, K., & Fry, E. A. (2015) · Genetics & Epigenetics · doi:10.4137/geg.s35500 · Cited by 87
B-Raf Inhibition in the Clinic: Present and Future
Fiskus, W. C., & Mitsiades, N. (2016) · Annual Review of Medicine · doi:10.1146/annurev-med-090514-030732 · Cited by 84
Pettersson, F., Rincon, S. V. D., Émond, A., Huor, B., Ngan, E., Ng, J., Dobocan, M. C., Siegel, P. M., & Miller, W. H. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-1996 · Cited by 83
Gahete, M. D., Córdoba‐Chacón, J., Hergueta‐Redondo, M., Martínez‐Fuentes, A. J., Kineman, R. D., Moreno‐Bueno, G., Luque, R. M., & Castano, J. P. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023302 · Cited by 81
PCR Techniques for Clonality Assays
Díaz‐Cano, S. J., Blanes, A., & Wolfe, H. J. (2001) · Diagnostic Molecular Pathology · doi:10.1097/00019606-200103000-00005 · Cited by 79
Emerging circulating biomarkers in glioblastoma: promises and challenges
Touat, M., Durán-Peña, A., Alentorn, A., Lacroix, L., Massard, C., & Idbaïh, A. (2015) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2015.1087315 · Cited by 79
Varley, K. E., Mutch, D. G., Edmonston, T. B., Goodfellow, P. J., & Mitra, R. D. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp457 · Cited by 78
Diagnosis of “Poorly Formed Glands” Gleason Pattern 4 Prostatic Adenocarcinoma on Needle Biopsy
Zhou, M., Li, J., Liang Cheng, C., Egevad, L., Deng, F.-M., Kunju, L. P., Magi‐Galluzzi, C., Melamed, J., Mehra, R., Mendrinos, S. E., et al. (2015) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000457 · Cited by 74
Molecular detection and targeting of EWSR1 fusion transcripts in soft tissue tumors
Cantile, M., Marra, L., Franco, R., Ascierto, P. A., Liguori, G., Chiara, A. D., & Botti, G. (2013) · Medical Oncology · doi:10.1007/s12032-012-0412-8 · Cited by 74
Romo‐Bucheli, D., Janowczyk, A. R., Gilmore, H. L., Romero, E., & Madabhushi, A. (2017) · Cytometry Part A · doi:10.1002/cyto.a.23065 · Cited by 74
Kumar, R., Liu, A. P. Y., Orr, B. A., Northcott, P. A., & Robinson, G. W. (2018) · Cancer · doi:10.1002/cncr.31583 · Cited by 74
Agarwal, R., Narayan, J., Bhattacharyya, A., Saraswat, M., & Tomar, A. K. (2017) · Cancer Genetics · doi:10.1016/j.cancergen.2017.06.002 · Cited by 71
Intratumor heterogeneity in epigenetic patterns
Assenov, Y., Brocks, D., & Gerhäuser, C. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.01.010 · Cited by 71
RAS/MAPK pathway hyperactivation determines poor prognosis in undifferentiated pleomorphic sarcomas
Serrano, C., Romagosa, C., Hernández‐Losa, J., Simonetti, S., Valverde, C., Moliné, T., Somoza, R., Pérez, M., Vélez, R., Vergés, R., et al. (2016) · Cancer · doi:10.1002/cncr.29733 · Cited by 59
Self-citationZonal Heterogeneity for Gene Expression in Human Pancreatic Carcinoma
Nakamura, T., Kuwai, T., Kitadai, Y., Sasaki, T., Fan, D., Coombes, K. R., Kim, S.-J., & Fidler, I. J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0874 · Cited by 57
Frequent intra-tumoural heterogeneity of promoter hypermethylation in malignant melanoma.
Rastetter, M., Schagdarsurengin, U., Lahtz, C., Fiedler, E., Marsch, W. C., Dammann, R., & Helmbold, P. (2007) · PubMed · doi:10.14670/hh-22.1005 · Cited by 55
Díaz-Cano, S. J., Blanes, A., Rubio, J., et al. (2000) · Laboratory Investigation · doi:10.1038/labinvest.3780033 · Cited by 55
The role of clonal communication and heterogeneity in breast cancer
Martín-Pardillos, A., Valls‐Chiva, A., Vargas, G. B., Hurtado, P., Piñeiro, R., Guijarro-Carrillo, P. J., Hümmer, S., Serrano, E., Rodríguez‐Casanova, A., Díaz‐Lagares, Á., et al. (2019) · BMC Cancer · doi:10.1186/s12885-019-5883-y · Cited by 55
Self-citationZhang, S., Jing, Y., Zhang, M., Zhang, Z., Ma, P., Peng, H., Shi, K., Gao, W., & Zhuang, G. (2015) · Scientific Reports · doi:10.1038/srep16066 · Cited by 54
y Cajal, S. R., Segura, M. F., & Hümmer, S. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00281 · Cited by 53
Role of epigenetics in lung cancer heterogeneity and clinical implication
Dong, N., Shi, L., Wang, D. C., Chen, C., & Wang, X. (2016) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2016.08.029 · Cited by 51
Receptor-Targeted Glial Brain Tumor Therapies
Sharma, P., & Debinski, W. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113326 · Cited by 51
Denisov, E. V., Литвяков, Н. В., Zavyalova, M. V., Михайлович, П. В., Vtorushin, S. V., Tsyganov, M. M., Gerashchenko, T. S., Garbukov, Е. Y., Slonimskaya, E. M., & Чердынцева, Н. В. (2014) · Scientific Reports · doi:10.1038/srep04709 · Cited by 48
Beyond molecular tumor heterogeneity: protein synthesis takes control
y Cajal, S. R., Castellví, J., Hümmer, S., Peg, V., Pelletier, J., & Sonenberg, N. (2018) · Oncogene · doi:10.1038/s41388-018-0152-0 · Cited by 47
Self-citationSánchez‐Prieto, R., LLeonart, M. E., & y Cajal, S. R. (1995) · PubMed · Cited by 45
Intratumoral Heterogeneity of MicroRNA Expression in Breast Cancer
Raychaudhuri, M., Schuster, T., Buchner, T., Malinowsky, K., Bronger, H., Schwarz‐Boeger, U., Höfler, H., & Avril, S. (2012) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2012.01.016 · Cited by 44
Martínez, A., Sesé, M., Hernández‐Losa, J., Robichaud, N., Sonenberg, N., Aasen, T., & y Cajal, S. R. (2015) · PLoS ONE · doi:10.1371/journal.pone.0123352 · Cited by 44
Self-citationy Cajal, S. R., Suster, S. M., Halaban, R., Filvaroff, E. H., & Dotto, G. P. (1991) · PubMed · Cited by 41
Building high-resolution synthetic lethal networks: a ‘Google map’ of the cancer cell
Paul, J., Templeton, S. D., Baharani, A., Freywald, A., & Vizeacoumar, F. J. (2014) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2014.09.009 · Cited by 39
The radiogenomic risk score stratifies outcomes in a renal cell cancer phase 2 clinical trial
Jamshidi, N., Jonasch, E. W., Zapala, M. A., Korn, R. L., Brooks, J. D., Ljungberg, B., & Kuo, M. (2015) · European Radiology · doi:10.1007/s00330-015-4082-8 · Cited by 36
Interplay between YB-1 and IL-6 promotes the metastatic phenotype in breast cancer cells
Castellana, B., Aasen, T., Moreno‐Bueno, G., Dunn, S. E., & y Cajal, S. R. (2015) · Oncotarget · doi:10.18632/oncotarget.5664 · Cited by 36
Self-citationSingle-Cell RNA Sequencing-Based Computational Analysis to Describe Disease Heterogeneity
Zeng, T., & Dai, H. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00629 · Cited by 36
General morphological and biological features of neoplasms: integration of molecular findings
Díaz-Cano, S. J. (2008) · Histopathology · doi:10.1111/j.1365-2559.2007.02937.x · Cited by 35
Single-cell transcriptional profiling reveals the heterogenicity in colorectal cancer
Dai, W., Zhou, F., Tang, D., Lin, L., Zou, C., Tan, W., & Dai, Y. (2019) · Medicine · doi:10.1097/md.0000000000016916 · Cited by 35
The effect of p-4E-BP1 and p-eIF4E on cell proliferation in a breast cancer model
y Cajal, S. R. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.1118 · Cited by 33
DNA and kinetic heterogeneity during the clonal evolution of adrenocortical proliferative lesions
Blanes, A., & Díaz‐Cano, S. J. (2006) · Human Pathology · doi:10.1016/j.humpath.2006.04.025 · Cited by 29
Derivation of a fifteen gene prognostic panel for six cancers
Khirade, M. F., Lal, G., & Bapat, S. A. (2015) · Scientific Reports · doi:10.1038/srep13248 · Cited by 28
Campbell, L., Jasani, B., Griffiths, D. F., & Gumbleton, M. (2015) · Europe PMC (PubMed Central) · Cited by 26
Blanes, A., Sanchez-Carrillo, J. J., & Díaz‐Cano, S. J. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1645 · Cited by 25
Horning, S. J. (2017) · Science · doi:10.1126/science.aan1295 · Cited by 25
y Cajal, S. R., Mattos‐Arruda, L. D., Sonenberg, N., Cortés, J., & Peg, V. (2014) · Clinical & Translational Oncology · doi:10.1007/s12094-014-1203-9 · Cited by 22
Cancer as an ecomolecular disease and a neoplastic consortium
y Cajal, S. R., Capdevila, C., Hernández‐Losa, J., Mattos‐Arruda, L. D., Ghosh, A., Lorent, J., Larsson, O. S., Aasen, T., Postovit, L.-M. M., & Topisirović, I. (2017) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.09.004 · Cited by 21
Self-citationAutomated decision support in melanocytic lesion management
Gilmore, S. J. (2018) · PLoS ONE · doi:10.1371/journal.pone.0203459 · Cited by 19
Methylation and intratumoural heterogeneity of 14-3-3 σ in oral cancer
BHAWAL, U. K., Tsukinoki, K., Sasahira, T., Sato, F., Mori, Y., Muto, N., Sugiyama, M., & Kuniyasu, H. (2007) · Oncology Reports · doi:10.3892/or.18.4.817 · Cited by 17
Rapid Research Autopsy: Piecing the Puzzle of Tumor Heterogeneity
Krook, M. A., Chen, H., Bonneville, R., Allenby, P., & Roychowdhury, S. (2018) · Trends in cancer · doi:10.1016/j.trecan.2018.11.004 · Cited by 17
y Cajal, S. R., Hümmer, S., Peg, V., Matías‐Guiu, X., de Torres, I. M., Castellví, J., Martínez-Sáez, E. A., & Hernández‐Losa, J. (2019) · Histopathology · doi:10.1111/his.13828 · Cited by 12
Self-citationTopisirović, I., & Sonenberg, N. (2015) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2015.05.004 · Cited by 10
y Cajal, S. R., Missero, C., Marchetti, E., & Dotto, G. P. (1994) · PubMed Central · Cited by 9
Denisov, E. V., Skryabin, N. A., Vasilyev, S. А., Gerashchenko, T. S., Лебедев, И. Н., Zavyalova, M. V., Чердынцева, Н. В., & Михайлович, П. В. (2015) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2015-203009 · Cited by 8
A PanorOmic view of personal cancer genomes
Mateo, L., Guitart-Pla, O., Pons, C., Duran‐Frigola, M., Mosca, R., & Aloy, P. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx311 · Cited by 5
Hoadley, K. A., Siegel, M. B., Kanchi, K., Miller, C. A., Ding, L., Zhao, W., He, X., Parker, J. S., Wendl, M. C., Fulton, R. S., et al. (2017) · PLoS Medicine · doi:10.1371/journal.pmed.1002222 · Cited by 2
Research works printed but not linked: 18
- Gomez-Martin C, Concha A, Corominas JM, Garcia-Caballero T, Garcia-Garcia E, Iglesias M, Lopez JA, Ramon y Cajal S, Rojo F, Palacios J et al (2011) Consensus of the Spanish Society of Medical Oncology (SEOM) and Spanish Society of Pathology (SEAP) for HER2 testing in gastric carcinoma. Clin Transl Oncol 13(9):636–651 · doi:10.1007/s12094-011-0709-7
- Abe H, Kawahara A, Azuma K, Taira T, Takase Y, Fukumitsu C, Murata K, Yamaguchi T, Akiba J, Ishii H et al (2015) Heterogeneity of anaplastic lymphoma kinase gene rearrangement in non-small-cell lung carcinomas: a comparative study between small biopsy and excision samples. J Thorac Oncol 10(5):800–805 · DOI
- Chang F (2006) Desmoplastic small round cell tumors: cytologic, histologic, and immunohistochemical features. Arch Pathol Lab Med 130(5):728–732 · doi:10.5858/2006-130-728-dsrctc
- Eriksen AH, Andersen RF, Nielsen BS, Sorensen FB, Appelt AL, Jakobsen A, Hansen TF (2016) Intratumoral heterogeneity of microRNA expression in rectal cancer. PLoS One 11(6):e0156919 · DOI
- Argani P, Fritsch M, Kadkol SS, Schuster A, Beckwith JB, Perlman EJ (2000) Detection of the ETV6-NTRK3 chimeric RNA of infantile fibrosarcoma/cellular congenital mesoblastic nephroma in paraffin-embedded tissue: application to challenging pediatric renal stromal tumors. Mod Pathol 13(1):29–36 · doi:10.1038/modpathol.3880006
- Sanchez-Prieto R, Vargas JA, Carnero A, Marchetti E, Romero J, Durantez A, Lacal JC, Ramon y Cajal S (1995) Modulation of cellular chemoresistance in keratinocytes by activation of different oncogenes. Int J Cancer 60(2):235–243 · doi:10.1002/ijc.2910600218
- Sanchez-Prieto R, Quintanilla M, Cano A, Leonart ML, Martin P, Anaya A, Ramon y Cajal S (1996) Carcinoma cell lines become sensitive to DNA-damaging agents by the expression of the adenovirus E1A gene. Oncogene 13(5):1083–1092
- Duque PM, Alonso C, Sanchez-Prieto R, Quintanilla M, Ramon S, Ramon y Cajal S (1998) Antitumoral effect of E1B defective adenoviruses in human malignant cells. Gene Ther 5(2):286–287 · doi:10.1038/sj.gt.3300585
- Blanes A, Diaz-Cano SJ (2006) Complementary analysis of microsatellite tumor profile and mismatch repair defects in colorectal carcinomas. World J Gastroenterol 12(37):5932–5940 · DOI
- Mattos-Arruda LD, Sammut S-J, Ross EM, Bashford-Rogers R, Greenstein E, Morganella S, Rueda OM, Martinez-Saez E, Peg V, Cortés J et al (2018) The integrated genomic and immune landscapes of lethal metastatic breast cancer (MBC). J Clin Oncol 36(15_suppl):1009–1009 · doi:10.1200/jco.2018.36.15_suppl.1009
- Blanes A, Rubio J, Martinez A, Wolfe HJ, Diaz-Cano SJ (2002) Kinetic profiles by topographic compartments in muscle-invasive transitional cell carcinomas of the bladder: role of TP53 and NF1 genes. Am J Clin Pathol 118(1):93–100 · doi:10.1309/8qr9-2fre-jphf-vrc6
- Blanes A, Rubio J, Sanchez-Carrillo JJ, Diaz-Cano SJ (2009) Coexistent intraurothelial carcinoma and muscle-invasive urothelial carcinoma of the bladder: clonality and somatic down-regulation of DNA mismatch repair. Hum Pathol 40(7):988–997 · doi:10.1016/j.humpath.2008.12.009
- Diaz-Cano SJ (2007) Kinetic topographical heterogeneity in follicular thyroid neoplasms and growth patterns. Histopathology 51(3):416–418 · doi:10.1111/j.1365-2559.2007.02778.x
- Pozo L, Sanchez-Carrillo JJ, Martinez A, Blanes A, Diaz-Cano SJ (2007) Differential kinetic features by tumour topography in cutaneous small-cell neuroendocrine (Merkel cell) carcinomas. J Eur Acad Dermatol Venereol 21(9):1220–1228 · doi:10.1111/j.1468-3083.2007.02236.x
- Diaz-Cano SJ (2000) Designing a molecular analysis of clonality in tumours. J Pathol 191(4):343–344 · doi:10.1002/1096-9896(200008)191:4<343::aid-path617>3.0.co;2-y
- Diaz-Cano SJ (2001) Are PCR artifacts in microdissected samples preventable? Hum Pathol 32(12):1415–1416 · doi:10.1053/hupa.2001.29632
- Cao J, Packer JS, Ramani V, Cusanovich DA, Huynh C, Daza R, Qiu X, Lee C, Furlan SN, Steemers FJ et al (2017) Comprehensive single-cell transcriptional profiling of a multicellular organism. Science 357(6352):661–667 · doi:10.1126/science.aam8940 · Paper page
- De Mattos-Arruda L, Caldas C (2016) Cell-free circulating tumour DNA as a liquid biopsy in breast cancer. Mol Oncol 10(3):464–474 · DOI
Cited by
Glioblastoma multiforme (GBM): An overview of current therapies and mechanisms of resistance
Wu, W., Klockow, J. L., Zhang, M., Lafortune, F., Chang, E., Jin, L., Wu, Y., & Daldrup-Link, H. E. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105780 · Cited by 805
Immune evasion in cancer: mechanisms and cutting-edge therapeutic approaches
Tufail, M., Jiang, C.-H., & Li, N. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02280-1 · Cited by 363
Arora, R., Cao, C., Kumar, M., Sinha, S., Chanda, A., McNeil, R., Samuel, D., Arora, R. K., Matthews, T. W., Chandarana, S., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40271-4 · Cited by 325
Spatial genomics enables multi-modal study of clonal heterogeneity in tissues
Zhao, T., Chiang, Z. D., Morriss, J. W., LaFave, L. M., Murray, E. M., Del Priore, I., Meli, K., Lareau, C. A., Nadaf, N. M., Li, J., et al. (2022) · Nature · doi:10.1038/s41586-021-04217-4 · Cited by 268
Truong, L.-H., & Pauklin, S. (2021) · Cancers · doi:10.3390/cancers13195028 · Cited by 102
Metadata
- Authors
- Ramón y Cajal, S., Sesé, M., Capdevila, C., Aasen, T., De Mattos-Arruda, L., Diaz-Cano, S. J., Hernández-Losa, J., & Castellví, J.
- Venue
- Journal of Molecular Medicine
- Published
- 2020-01-22
- Volume
- 98
- Issue
- 2
- Pages
- 161-177
- ISSN
- 0946-2716 (ISSN-L)
- 1432-1440
- OpenAlex
- W3002685488
- Cited by
- 514
- References
- 190
- FWCI
- 18.19
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Funders
- Instituto de Salud Carlos III (PI17/02247, PI14/01320)
- Agència de Gestió d’Ajuts Universitaris i de Recerca (2017 SGR 1799)
- Centro de Investigación Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina (CB16/12/00363 CIBERONC)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.